相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diverse IgG Subclass Responses to Adeno-Associated Virus Infection and Vector Administration
Samuel L. Murphy et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth et al.
HUMAN GENE THERAPY (2008)
HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population
C. Dunne et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2008)
Complement is an essential component of the immune response to adeno-associated virus vectors
Anne K. Zaiss et al.
JOURNAL OF VIROLOGY (2008)
A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in Dogs
Yongping Yue et al.
MOLECULAR THERAPY (2008)
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: A Randomized placebo-controlled phase 2B trial
Richard B. Moss et al.
HUMAN GENE THERAPY (2007)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets
Lili Wang et al.
HUMAN GENE THERAPY (2007)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 α1-antitrypsin (AAT) vector in AAT-deficient adults
Mark L. Brantly et al.
HUMAN GENE THERAPY (2006)
Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors
CL Halbert et al.
HUMAN GENE THERAPY (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Determination of specific CD4 and CD8 T cell epitopes after AAV2-and AAV8-hF.IX gene therapy
J Chen et al.
MOLECULAR THERAPY (2006)
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
DE Sabatino et al.
MOLECULAR THERAPY (2005)
Immune responses to adeno-associated virus vectors
AK Zaiss et al.
CURRENT GENE THERAPY (2005)
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
VR Arruda et al.
BLOOD (2005)
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis - A multicenter, double-blind, placebo-controlled trial
RB Moss et al.
CHEST (2004)
Clades of Adeno-associated viruses are widely disseminated in human tissues
GP Gao et al.
JOURNAL OF VIROLOGY (2004)
Receptor targeting of adeno-associated virus vectors
H Büning et al.
GENE THERAPY (2003)
Vectors for the treatment of autoimmune disease
DJ Gould et al.
GENE THERAPY (2003)
Ocular immune privilege: Therapeutic opportunities from an experiment of nature
JW Streilein
NATURE REVIEWS IMMUNOLOGY (2003)
A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease
JM Zhang et al.
NEUROBIOLOGY OF DISEASE (2003)
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Q Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
AK Zaiss et al.
JOURNAL OF VIROLOGY (2002)
Impaired gamma interferon responses against parvovirus B19 by recently infected children
A Corcoran et al.
JOURNAL OF VIROLOGY (2000)
Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors
WD Xiao et al.
MOLECULAR THERAPY (2000)
AAV vectors: is clinical success on the horizon?
PE Monahan et al.
GENE THERAPY (2000)
分享论文
